Washington State Legislature

Bill Information > HB 2565

Search for another bill or initiative:

Bill Initiative

HB 2565 - 2017-18

Concerning drug and gene therapy payment for medicaid managed care organizations.

Sponsors: Schmick

Bill History

2018 REGULAR SESSION

IN THE HOUSE

Jan 10

First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (View Original Bill)

Jan 30

Public hearing in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)

Jan 31

Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)

Feb 2

Executive action taken in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)

HCW - Majority; 1st substitute bill be substituted, do pass. (View 1st Substitute) (Majority Report)

Referred to Rules 2 Review.

Feb 6

Placed on second reading by Rules Committee.

Feb 9

1st substitute bill substituted (HCW 18). (View 1st Substitute)

Floor amendment(s) adopted.

Rules suspended. Placed on Third Reading.

Third reading, passed; yeas, 98; nays, 0; absent, 0; excused, 0. (View 1st Engrossed) (View Roll Calls)

IN THE SENATE

Feb 13

First reading, referred to Health & Long Term Care.

Mar 8

By resolution, returned to House Rules Committee for third reading.

Available Documents

For a complete list of documents, go to Online Reports Text of a Legislative Document.

Fiscal Note

Amendments

Available Videos